new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one provider empowering you from Sample to Insight.
The Summer 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expand...
New content, new projects, External Scripts improvements and more! Content updates Recently-added ...
Researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in...
As part of our effort to provide enhanced user experiences for the Human Gene Mutation Database (HGM...
QIAGEN Discovery Bioinformatics Services offer custom solutions that help translate discovery from y...
HGMD Professional 2020.2 Release
What’s new in the QIAGEN OmicSoft 2020R1 and 2020R1.1 releases
QIAGEN Digital Insights Publication Roundup (Summer 2020)
New changes to how you login to HGMD Professional and download HGMD data, GenomeTrax, and ANNOVAR
Antibody Analysis Suite: A custom solution from QIAGEN Discovery Bioinformatics Services
Targeted NGS panels and optimized analysis and interpretation tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients